SeaStar Medical Holding Corp (ICU) Form S-3 — Oct 30, 2026
SeaStar Medical filed an S-3 resale registration statement covering up to 1,767,784 shares issuable upon exercise of warrants issued in an October 2026 warrant inducement deal, including 854,002 Series A warrant shares, 854,002 Series B warrant shares, and 59,780 placement agent warrant shares. The company receives no proceeds from these resales, though full cash exercise of the new warrants ($3.616 and $4.8325 strikes) would bring in roughly $6.5 million. The registered shares equal roughly 33% of the 5,315,967 shares outstanding before the offering, and the filing itself flags that sales by the selling stockholders could depress the stock price and encourage short selling.
Key figures
- Offering Price
- 2.6895
- Shares Offered
- 1767784
- Shares Outstanding
- 5315967
- Registration fee usd
- 413.64
- Last sale price oct 29 2026
- 2.31
- Shares outstanding post offering
- 7083751
- Warrant exercise price series a b
- 3.616
- Prior warrant exercise proceeds usd
- 3300000
- Potential cash exercise proceeds usd
- 6500000
- Reduced exercise price prior warrants
- 3.866
- Warrant exercise price placement agent
- 4.8325
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.